ArticleCancers2022

Efficacy of Oncolytic Herpes Simplex Virus T-VEC Combined with BET Inhibitors as an Innovative Therapy Approach for NUT Carcinoma.

Paul V Ohnesorge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.